Naptumomab是一种融合蛋白,由单克隆抗体的抗原结合片段(Fab)与超抗原葡萄球菌肠毒素A(SEA/E-120,“依他芬那妥”)组成。Fab与各种肿瘤细胞表达的抗原5 T4结合,超抗原通过活化T淋巴细胞诱导免疫应答。 Naptumomab生物仿制药-研究级该产品同种型对照:Bulk Human IgG1 Isotype Control (IB1) [ICH2254] 缓冲液:ICH3002 浓度:5mg/ml 纯度:>95% by SDS-PAGE 内毒素:≤ 1.0 EU/mg as determined by the LAL method 制剂:Sterile, preservative-free, solution in PBS. BSA and Azide free.